In silico screening of alkaloids as potential inhibitors of epidermal growth factor receptor
Từ khóa:
Tóm tắt
The epidermal growth factor receptor (EGFR) belongs to the HER/erbB receptor tyrosine kinase (RTK) family, serving as a crucial target for cancer treatment. Anti-EGFR drugs, used as a primary treatment for patients with advanced EGFR gene mutations such as T790M, C797S, and L858R, have shown greater efficacy and safety compared to standard chemotherapy...
Lượt tải
Chưa có dữ liệu tải xuống.
Đã Xuất bản
2023-09-14
Số
Chuyên mục
LIFE SCIENCES